Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Venadaparib by Idience for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
Venadaparib is under clinical development by Idience and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas. According to GlobalData,...
Data Insights
Venadaparib by Idience for Gastric Cancer: Likelihood of Approval
Venadaparib is under clinical development by Idience and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...